Patents by Inventor Joseph A. Baldone

Joseph A. Baldone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of virus infections with ganglionic blocking agents
    Patent number: 5686448
    Abstract: A method for preventing or treating infection or disease in a mammal caused by a virus, such as herpes simplex virus type 1 and 2. A ganglionic blocking agent, such as tetraethylammonium ion or hexamethonium ions, is administered to the mammal in an effective dosage.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 11, 1997
    Assignee: Baltech, Inc.
    Inventor: Joseph A. Baldone
  • Treatment of diseases caused by herpes viruses
    Patent number: 5158980
    Abstract: This invention pertains to a method of treating diseases caused by Herpes Simplex Virus (HSV) Types 1 and 2. Disclosed herein is a method of treatment that, through the use of Tetraethylammonium Ion (TEA) achieves a selective and specific inhibition of viral function in diseases caused by HSV Types 1 and 2. TEA can be provided in the form of its chloride salt, unpreserved for individual doese, or with preservatives for multiple dose vials.
    Type: Grant
    Filed: September 26, 1991
    Date of Patent: October 27, 1992
    Assignee: Baltech, Inc.
    Inventor: Joseph A. Baldone
  • Treatment of diseases caused by herpes viruses
    Patent number: 4935448
    Abstract: This invention pertains to a method of treating diseases caused by Herpes Simplex Virus (HSV) Types 1 and 2. Disclosed herein is a method of treatment that, through the use of Tetraethylammonium Ion (TEA) achieves a selective and specific inhibition of viral function in diseases causes by HSV Types 1 and 2. TEA can be provided in the form of its chloride salt, unpreserved for individual doses, or with preservatives for multiple dose vials.
    Type: Grant
    Filed: May 18, 1988
    Date of Patent: June 19, 1990
    Inventor: Joseph A. Baldone
  • Treatment of virus infections with quaternary ammonium compounds
    Patent number: 4902720
    Abstract: A method for preventing or treating infection or disease in a mammal caused by a virus, such as herpes simplex virus type 1 and 2. A quaternary ammonium compound, such as tetraethylammonium ion or hexamethonium ion, is administered to the mammal in an effective dosage.
    Type: Grant
    Filed: July 5, 1988
    Date of Patent: February 20, 1990
    Inventor: Joseph A. Baldone
  • Treatment of virus infections with ganglionic blocking agents
    Patent number: 4898888
    Abstract: A method for preventing or treating infection or disease in a mammal caused by a virus, such as herpes simplex virus type 1 and 2. A ganglionic blocking agent, such as tetraethylammonium ion or hexamethonium ion, is administered to the mammal in an effective dosage.
    Type: Grant
    Filed: October 5, 1988
    Date of Patent: February 6, 1990
    Inventor: Joseph A. Baldone
  • Treatment of diseases caused by herpes viruses
    Patent number: 4760079
    Abstract: This invention pertains to a method of treating diseases caused by Herpes Simplex Virus (HSV) Types 1 and 2. Disclosed herein is a method of treatment that, through the use of Tetraethylammonium Ion (TEA) achieves a selective and specific inhibition of viral function in diseases caused by HSV Types 1 and 2. TEA can be provided in the form of its chloride salt, unpreserved for individual doses, or with preservatives for multiple dose vials.
    Type: Grant
    Filed: August 4, 1987
    Date of Patent: July 26, 1988
    Assignee: Baltech, Inc.
    Inventor: Joseph A. Baldone